CSF2 and Decreased total leukocyte count: According to the literature, Zol and the RANKL inhibitor OPG blocked GM-CSF-induced tumor growth in bone, but this did not affect the capability of GM-CSF to reverse chemotherapy-induced leukopenia [38].